Seoul National University Bundang Hospital in Seoul, South Korea, was recently approved for Phase 6 of the classic HIMSS study Analytical maturity assessment model.
AMAM measures an organization’s capabilities and progress in health analytics. A fresh, modernized version of this model – dubbed AMAM24 – was launched during the recently concluded HIMSS24 APAC conference.
WHY IT’S IMPORTANT
SNUBH attributes its latest achievement to confirmation of previous experience four times in HIMSS Stage 7 A model for the adoption of electronic medical records. The data convergence team within the Hospital Information Office led this process and ensured close collaboration between the health informatics teams and the hospital’s operational teams.
One of the highlights of the validation is CDW 3.0, an improved version of the clinical data warehouse the hospital has been using for a decade. SNUBH began this modernization two years ago to create an “advanced open-source data warehouse equipped with machine learning capabilities.”
After launching CDW 3.0 in October last year, SNUBH employees noticed an enhance in the speed of data search and analysis thanks to the system. CDW now has a user-friendly interface that allows you to define patient cohorts step by step. It also improves data visualization; increases data security thanks to masking and anonymization modules; standardizes unstructured data and adapts to international standard codes; and provides a single source of educational resources, including predefined datasets for ML/AI research.
In its validation, HIMSS noted that the consolidated CDW was “accessible, convenient and user-friendly.” “This makes it an incredibly powerful tool for executives and clinicians to view, understand and analyze data and generate insights to improve clinical care and organizational performance,” commented Andrew Pearce, HIMSS vice president of analytics and global consulting leader.
Validators also praised SNUBH for tracking and reporting over 200 metrics through several dashboards. An example of this is the Rapid Response System (RRS) dashboard. The hospital first created the RRS system in 2012 to address typical delays in responding to patient deterioration.
Currently, in the second phase of implementation, RRS operates 24/7 and employs 15 nurses. The hospital has seen a “significant reduction” in the number of cardiopulmonary resuscitation cases on general wards in the ten years since the system was first launched. Another noticeable improvement is the RRS dashboard, which facilitates the rapid transfer of patients to the ICU.
Additionally, during the AMAM validation, SNUBH demonstrated the implementation of an AI-based ECG interpretation tool in the HIS, which is now used to generate quantitative risk scores for cardiac events and assist in the diagnosis of arrhythmias and other related emergencies.
The aim of the project is to eliminate delays in detecting cardiac problems and enable the creation of personalized treatment plans. Based on a pilot test conducted prior to its initial integration in April this year, the AI tool has demonstrated proficiency in rhythm analysis and classification of 10 identified digital biomarkers.
Following clinical integration, SNUBH clinicians highlighted the tool’s ability to diagnose severe hyperkalemia early. Evaluation studies are ongoing to further prove its effectiveness.
Following AMAM approval, SNUBH continues with plans to strengthen its enterprise data warehouse and improve operational data analytics capabilities, focusing on end-of-life monitoring systems to address the analytical lifecycle – which is now part of the modernized AMAM.
A BIGGER TREND
A colleague from a Korean hospital, Samsung Medical Center was the first hospital in the Asia-Pacific region to be certified for stage 7 of the HIMSS AMAM study in May. Last year, it was the first in the region to reach stage 6.
Outside South Korea, China Medical University Taiwan Hospital is also currently HIMSS AMAM Stage 6 certified.
Meanwhile, overdue last year, SNUBH passed its fourth validation for HIMSS EMRAM. There was a hospital was the first outside the United States to be approved for Stage 7 of this model in 2010.
ON RECORDING
“SNUBH has been consistently developing its data analytics capabilities, which have been progressively validated through our previous four EMRAM certifications. I am delighted that we have once again validated our data analytics competencies through AMAM Stage 6 certification. This achievement recognizes not only our current capabilities but also sets the stage for our continued progress in using data to improve healthcare delivery and excellence operational,” Dr. Junghan Song, president and CEO of SNUBH, said in a statement.
“Specifically, we selected the HIMSS AMAM validation to strengthen our data-driven decision-making capabilities and assess the current state of our data platforms. SNUBH has evolved alongside HIMSS certifications and we are committed to continuing this journey into the future. As highlighted at HIMSS APAC 2024, the newly modernized AMAM validation is well designed. With this framework, we once again aim to drive innovation in data-driven decision-making, both in our clinical and operational domains,” Dr. Seyoung Jung, CIO at SNUBH, also commented.